Company Filing History:
5 out of 76 
1 out of 92 
Years Active: 2001-2014
Title: James B. Hoffman: Innovator in Pharmaceutical Sciences
Introduction
James B. Hoffman, a prominent inventor based in Ardmore, Pennsylvania, has made significant contributions to the field of pharmaceutical sciences, particularly through his innovative research on peptide deformylase inhibitors and protease inhibitors. With a notable portfolio of six patents, Hoffman continues to advance the understanding and treatment of bacterial infections.
Latest Patents
Hoffman’s latest patents include a focus on peptide deformylase inhibitors, which are crucial in combating bacterial infections. His work relates to a compound of Formula (I), or a pharmaceutically acceptable salt thereof, along with corresponding pharmaceutical compositions, methods of preparation, and treatment methodologies aimed at inhibiting bacterial peptide deformylase (PDF) activity. Additionally, he has developed methodologies for heteroaryl amidines, methylamidines, and guanidines, highlighting their utility as protease inhibitors.
Career Highlights
Throughout his career, Hoffman has collaborated with notable institutions, including 3-Dimensional Pharmaceuticals, Inc. and GlaxoSmithKline Intellectual Property Limited. His experiences in these companies have contributed significantly to his innovative capacities and patent holdings, shaping the landscape of pharmaceutical treatment options.
Collaborations
Hoffman has worked alongside talented collaborators, such as Carl R. Illig and Nalin L. Subasinghe. These partnerships have fostered a creative environment that promotes innovative thinking and the successful development of new pharmaceutical applications.
Conclusion
In summary, James B. Hoffman stands out as an influential inventor within the pharmaceutical sector, driven by his passion for innovation and dedicated to advancing medical science through his patents. His work not only showcases his inventive spirit but also contributes to the broader effort to develop effective treatments for bacterial infections, making an impactful difference in the field.